Protein engineering is the process of developing valuable proteins or enzyme with a specific function. It is based on the use of the recombinant DNA technology for changing the amino acid sequence. It is used to produce enzyme in large quantities, for producing biological compounds, and to create a superior enzyme to catalyze the production of high value specific chemicals. Currently, various protein engineering methods are owing to the rapid development in biological science.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/4726
North America dominates the global market for protein engineering due to the rising prevalence of lifestyle associated diseases and increasing adoption of protein based drugs in the region. Asia Pacific is expected to exhibit high growth rates in the next five years in the global protein engineering market, with China and India being the fastest-growing markets in Asia Pacific. The key driving forces for the protein engineering market in developing countries are the large pool of patients, increasing health care awareness, increasing health care expenditure, rising government initiatives, and rising funding for drug discovery in the region.
Increasing prevalence of lifestyle associated diseases, growing adoption of protein based drugs over non protein based drugs, rising funding for protein engineering, reduction in overall timeline and cost for drug discovery, increase in health care expenditure, and growing health care awareness are some of the key factors that are driving the growth of the global protein engineering market. However, high maintenance, high cost of tools and instruments used in protein engineering, need for qualified researchers and essential training, which increases the cost of the process, and lack of skilled labor act as major restraints for the growth of the global protein engineering market.
Top selling biologics drugs going off patent in the near future, and protein therapy acting as an alternative to gene therapy are the two major factors that are expected to create opportunities for the global protein engineering market.
Key segments covered in this report are:
- By product
- Services and software
- By technology
- Rational protein design
- Irrational protein design
- By protein type
- Monoclonal antibodies
- Colony stimulating factor
- Growth hormones
- By end users
- Academic research institutes
- Pharmaceutical and biotechnology companies
- Contract research organization
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/4726
Top companies profiled in this report are:
- Agilent Technologies, Inc.
- Danaher Corporatio
- Bio-Rad Laboratories, Inc.
- Burker Corporation
- Sigma-Aldrich Corporation
- General Electric Company
- Genscripts, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- Waters Corporation.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353